Stock Markets
Teladoc stock target cut, maintains hold rating on Q1 results
On Monday, Jefferies revised its financial outlook on Teladoc Health Inc (NYSE:), reducing the stock price target to $14.00 from the previous $16.00 while maintaining a Hold rating. The adjustment follows the evaluation of the company’s first-quarter results and the latest guidance provided by its management. The firm has moderated its expectations for Teladoc’s BetterHelp business, noting that year-over-year comparisons are showing a negative trend.
The firm’s analyst stated that the updated model takes into account the recent quarterly performance and comments from the management team. As a result, the revenue and EBITDA forecasts for the fiscal years 2024 through 2026 have been revised.
The new projections for revenue are now set at $2,625 million for 2024, $2,724 million for 2025, and $2,798 million for 2026. Similarly, the EBITDA estimates have been adjusted to $362 million for 2024, $393 million for 2025, and $414 million for 2026.
These updated figures represent a decrease from the previous estimates, which had the revenue at $2,671 million for 2024, $2,738 million for 2025, and $2,794 million for 2026, with EBITDA at $367 million for 2024, $391 million for 2025, and $409 million for 2026. The changes reflect a more conservative outlook for the company’s performance over the next few years.
The analyst reiterated the Hold rating on Teladoc shares, suggesting that investors maintain their current positions without increasing or decreasing their stake in the company. The revised price target and financial estimates are based on the latest available data and the firm’s analysis of the company’s business trajectory.
Teladoc Health Inc, listed on the New York Stock Exchange, is a telemedicine and virtual healthcare company. It has been closely watched by investors as the telehealth sector experiences shifts in consumer behavior and regulatory environments. The updated guidance from Jefferies provides a current perspective on the company’s financial health and market position.
InvestingPro Insights
As Teladoc Health Inc (NYSE:TDOC) navigates through a challenging period, real-time data from InvestingPro offers additional context to Jefferies’ revised financial outlook. The company’s market capitalization stands at $2.11 billion, reflecting its current valuation in the market.
Despite the downward revision of earnings by analysts, Teladoc’s valuation implies a strong free cash flow yield, suggesting potential for investor returns. Still, it is critical to note that analysts do not expect the company to be profitable this year, which is an important consideration for investors.
On a positive note, Teladoc’s liquid assets surpass its short-term obligations, indicating a degree of financial flexibility. Yet, the firm is trading near its 52-week low and has not been profitable over the last twelve months, factors that might concern investors looking for immediate profitability.
Moreover, the stock has seen a significant price drop over the last three months, which could either signal a buying opportunity for value investors or a red flag for those wary of declining stock performance.
Investors interested in a deeper analysis can find more InvestingPro Tips on Teladoc, including insights on EBITDA valuation multiples and dividend policies. For those looking to leverage these insights, InvestingPro offers additional tips—more than eight for Teladoc alone. To enrich your investment decision-making, consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Stock Markets
Trump transition team plans immediate WHO withdrawal, expert says
By Maggie Fick and Ahmed Aboulenein
WASHINGTON (Reuters) – Members of Donald Trump’s presidential transition team are laying the groundwork for the United States to withdraw from the World Health Organization on the first day of his second term, according to a health law expert familiar with the discussions.
“I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration,” said Lawrence Gostin, professor of global health at Georgetown University in Washington and director of the WHO Collaborating Center on National and Global Health (NS:) Law.
The Financial Times was first to report on the plans, citing two experts. The second expert, former White House COVID-19 response coordinator Ashish Jha, was not immediately available for comment.
The Trump transition team did not immediately respond to a Reuters request for comment.
The plan, which aligns with Trump’s longstanding criticism of the U.N. health agency, would mark a dramatic shift in U.S. global health policy and further isolate Washington from international efforts to battle pandemics.
Trump has nominated several critics of the organization to top public health positions, including Robert F. Kennedy Jr., a vaccine skeptic who is up for the post of secretary of Health and Human Services, which oversees all major U.S. health agencies including the CDC and FDA.
Trump initiated the year-long withdrawal process from the WHO in 2020 but six months later his successor, President Joe Biden, reversed the decision.
Trump has argued that the agency failed to hold China accountable for the early spread of COVID-19. He has repeatedly called the WHO a puppet of Beijing and vowed to redirect U.S. contributions to domestic health initiatives.
A WHO spokesperson declined to directly comment but referred Reuters to comments by WHO Director-General Tedros Adhanom Ghebreyesus at a press briefing on Dec. 10 in which he was asked whether he was concerned that the Trump administration would withdraw from the organization.
Tedros said at the time that the WHO needed to give the U.S. time and space for the transition. He also voiced confidence that states could finalize a pandemic agreement by May 2025.
Critics warn that a U.S. withdrawal could undermine global disease surveillance and emergency response systems.
“The U.S. would lose influence and clout in global health and China would fill the vacuum. I can’t imagine a world without a robust WHO. But U.S. withdrawal would severely weaken the agency,” Gostin said.
Stock Markets
Just in: MicroStrategy Buys $561 Million More Bitcoin (BTC), Announces Saylor
U.Today – MicroStrategy has made headlines again by purchasing 5,262 BTC for approximately $561 million at an average price of $106,662 per BTC. The company now holds a staggering 444,262 BTC, accumulated at a total cost of approximately $27.7 billion, with an average purchase price of $62,257 per BTC.
Despite impressive returns of 47.4% since the beginning of the quarter and 73.7% since the beginning of the year, skepticism about the company’s strategy is growing.
It is believed that to sustain its purchases, MicroStrategy raises capital through methods such as issuing convertible and corporate bonds, securing credit lines and selling shares.
This cycle appears to operate as follows: shares are sold to acquire the cryptocurrency, and the rising price per BTC increases asset value, enabling further loans, which are then reinvested in more purchases.
Some observers warn that a significant decline in Bitcoin’s price or MicroStrategy’s stock could trigger a cascade effect. A sharp fall in MSTR shares would weaken the collateral backing its loans, potentially leading to forced asset sales, including BTC.
This scenario could exert downward pressure on the broader cryptocurrency market, as the company holds 2.2% of the global Bitcoin supply now.
Thus, while some view Michael Saylor’s approach as a bold bid to cement the cryptocurrency’s role in the financial system, others see it as unsustainable. History offers a cautionary note: in 2000, MSTR shares surged to $333 before plummeting 99%, a collapse that took 24 years to recover from.
Stock Markets
Taylor Morrison Named Among America’s Most Trusted and Best Companies by Forbes
National homebuilder ranked No. 12 on inaugural list ranking companies based on trust
SCOTTSDALE, Ariz., Dec. 23, 2024 /PRNewswire/ — With a longstanding reputation for trust, national homebuilder and land developer Taylor Morrison (NYSE:) (NYSE: ™HC) has been recognized by Forbes on their inaugural list of the Most Trusted Companies in America. The homebuilder ranked No. 12 out of 300 companies across all industries.
“There are few things more powerful than trust and it’s something we strive to earn amongst all company stakeholders, from our customers to our team members, our shareholders, and our local communities,” said Taylor Morrison Chairman and CEO Sheryl Palmer. “To be included on this esteemed list in its inaugural year is especially meaningful and these awards are important reminders of the relationships we’re building across all aspects of our business.”
Fueled by hundreds of millions of data points, the Most Trusted Companies in America list combines data on a wide range of factors across four categories: employee trust, customer trust, investor trust and media sentiment. The ranking was created in partnership with research companies HundredX, Signal AI and Glassdoor.
Taylor Morrison also earned the No. 67 spot on Forbes’ inaugural America’s Best Companies list. The ranking is Forbes’ most comprehensive company ranking to date and factored in ratings for financial performance, customer and employee satisfaction, cybersecurity, sustainability, companies’ remote work policies, media coverage and more. Forbes’ America’s Best Companies list assessed more than 60 metrics across 11 primary categories to identify which organizations excel across the board. Of the more than 2,000 U.S.-based publicly traded companies that were eligible, only 300 qualified for each list.
In addition to being named among the Most Trusted and Best Companies in America by Forbes, Taylor Morrison holds several additional accolades including being named on Newsweek’s America’s Most Responsible Companies and America’s Greenest Companies lists, U.S. News & World Report’s Best Companies to Work For list, the American Opportunity (SO:) Index, America’s Most Trusted ® Home Builder for nine years, Hearthstone’s 2021 BUILDER Humanitarian Award, and inclusion on the Fortune 500 list since 2021.
About Taylor Morrison
Headquartered in Scottsdale, Arizona, Taylor Morrison is one of the nation’s leading homebuilders and developers. We serve a wide array of consumers from coast to coast, including first-time, move-up, luxury and resort lifestyle homebuyers and renters under our family of brands”including Taylor Morrison, Esplanade and Yardly. From 2016-2024, Taylor Morrison has been recognized as America’s Most Trusted ® Builder by Lifestory Research. Our long-standing commitment to sustainable operations is highlighted in our annual Sustainability and Belonging Report.
For more information about Taylor Morrison, please visit www.taylormorrison.com.
CONTACT:
media@taylormorrison.com
- Forex2 years ago
Forex Today: the dollar is gaining strength amid gloomy sentiment at the start of the Fed’s week
- Forex2 years ago
How is the Australian dollar doing today?
- Forex2 years ago
Unbiased review of Pocket Option broker
- Forex2 years ago
Dollar to pound sterling exchange rate today: Pound plummeted to its lowest since 1985
- Cryptocurrency2 years ago
What happened in the crypto market – current events today
- World2 years ago
Why are modern video games an art form?
- Commodities2 years ago
Copper continues to fall in price on expectations of lower demand in China
- Forex2 years ago
The dollar is down again against major world currencies